Yes indeed, there are approved valves for ViV in Canada as well, but now that DurAVR has arrived with outstanding results those approved valves are no longer considered appropriate for ViV.
Based on the clear evidence of our early results I would suggest that HDE will happen at a minimum, and at this stage we might just be able to supply the cap.
As far as the share price goes, I think we will need to wait for the EGM to be out of the way and the EFS results read out at TCT in October. Then I expect the handbrake to be released.
AVR Price at posting:
$21.00 Sentiment: Buy Disclosure: Held
(20min delay)